KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Intangibles (2018 - 2025)

Twist Bioscience (TWST) has disclosed Intangibles for 5 consecutive years, with $59.7 million as the latest value for Q3 2022.

  • On a quarterly basis, Intangibles rose 204.32% to $59.7 million in Q3 2022 year-over-year; TTM through Sep 2022 was $59.7 million, a 204.32% increase, with the full-year FY2022 number at $59.7 million, up 204.32% from a year prior.
  • Intangibles was $59.7 million for Q3 2022 at Twist Bioscience, down from $62.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $62.5 million in Q1 2022 to a low of $307000.0 in Q3 2020.
  • A 5-year average of $16.4 million and a median of $976000.0 in 2018 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: plummeted 39.57% in 2020, then skyrocketed 6294.14% in 2021.
  • Twist Bioscience's Intangibles stood at $712000.0 in 2018, then crashed by 35.67% to $458000.0 in 2019, then tumbled by 32.97% to $307000.0 in 2020, then surged by 6294.14% to $19.6 million in 2021, then soared by 204.32% to $59.7 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Intangibles are $59.7 million (Q3 2022), $62.5 million (Q1 2022), and $19.6 million (Q3 2021).